Acurx net loss flat at $2.26 million in Q2 2026

ACXP•2026-08-13

Acurx posted a net loss of $2.26 million for the quarter ended June 30, 2026, little changed from a year earlier.
R&D expense climbed 104% to $1.07 million, driven by higher manufacturing costs and consulting fees tied to the recurrent CDI program.
G&A expense fell 29% to $1.24 million on lower professional fees, legal fees, and share-based compensation.
Cash totaled $10.7 million at June 30, 2026; working capital was $8.2 million.
An April registered direct offering raised about $2.5 million gross, with concurrent 24-month warrants issued for up to 1,650,170 shares at $2.78.

Sources

Sec